UCSF researchers identify patterns of genetic activity that could help in early detection of disorder that affects millions of women.
Under a new agreement, GE Healthcare will offer Caradigm’s identity and access management suite with Omnyx digital pathology solutions to streamline pathology workflows.
Massachusetts researchers find panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and more sensitive than exome sequencing.
A diagnostic technology from NanoSomiX may be useful in measuring prognosis and treatment of Alzheimer’s disease.
Singapore-based Vela Diagnostics has announced completion of the FDA listing of its next-generation sequencing system as a Class II medical device.
Updated ACS guidelines for colorectal cancer include recommended use of a noninvasive stool-based DNA screening test every 3 years.
A new partnership between BBI Solutions and Genisphere will focus on developing lateral-flow rapid test applications with heightened levels of sensitivity.
Presentations at ACR are expected to offer new data about the diagnostic and clinical utility of blood tests for the protein 14-3-3 eta, considered a mechanistic biomarker for rheumatoid arthritis.
A CDC study suggests there is room for improvement in current approaches for screening and prevention of cervical cancer.
US testing for chikungunya is unlikely to taper off during the fall and winter, as travelers returning from outbreak areas remain at risk.